prismIndustries

Introduction to Custom API Development Custom API development plays an important role in the pharmaceutical industry by helping companies develop and manufacture active pharmaceutical ingredients (APIs) according to specific technical, quality, and production requirements. From initial chemical research to commercial manufacturing, the process involves careful planning, scientific evaluation, and quality management at every stage. Pharmaceutical companies may require custom API development when an existing manufacturing process needs improvement, a specialised molecule requires development, or production must be adapted to meet commercial demand. A well-planned development strategy can help improve process efficiency, manage impurities, maintain consistent product quality, and support long-term manufacturing requirements. For pharmaceutical businesses, selecting an experienced API development and manufacturing partner is an important decision. Companies such as Prism Industries Pvt. L...

  Malaria remains a persistent global health challenge, particularly across regions where Plasmodium falciparum has developed resistance to traditional monotherapies. To counter this, international health protocols heavily emphasize Artemisinin-based Combination Therapies (ACTs). Within these co-formulations, Lumefantrine serves as a vital partner molecule, offering a prolonged half-life that clears residual parasites after the fast-acting artemisinin derivative completes its initial phase. For pharmaceutical formulators, selecting a high-grade active pharmaceutical ingredient (API) is not simply a matter of procurement; it directly affects drug stability, bio-absorption, and therapeutic consistency. Lumefantrine USP has established itself as the quality benchmark for manufacturers aiming to produce reliable, compliant malaria treatments . The Role of Lumefantrine USP in Artemisinin-Based Combination Therapies The therapeutic strategy behind Artemisinin-Based Combination Therapie...

  Hyoscine hydrobromide is a pharmaceutical compound known for its role in preventing motion sickness and managing certain symptoms associated with nausea and vomiting. Its particular effects on the nervous system distinguish it from several other anticholinergic medicines. For pharmaceutical manufacturers, understanding these differences is useful when evaluating the compound's applications, quality requirements, and position within the broader active pharmaceutical ingredient (API) market. Although many anticholinergic medicines act on acetylcholine signalling, they are not interchangeable. Their effects depend on the receptors they influence, how they enter the body, their distribution in tissues, and the conditions for which they are prescribed. This article explores how hyoscine hydrobromide compares with other medicines in its class, what makes its pharmacological profile distinctive, and which manufacturing and sourcing factors matter when assessing hyoscine hydrobromide AP...